Literature DB >> 3047215

Comparison of beclomethasone dipropionate and prednisolone 21-phosphate enemas in the treatment of ulcerative proctitis.

H van der Heide1, V van den Brandt-Gradel, G N Tytgat, E Endert, E H Wiltink, M E Schipper, W Dekker.   

Abstract

In a double-blind randomized clinical trial 18 patients with exacerbations of distal ulcerative colitis were treated for 4 weeks with enemas containing either prednisolone 21-phosphate 30 mg (PP) or beclomethasone dipropionate 1 mg (BDP) a surface-active corticosteroid. All 8 patients treated with PP showed clinical and endoscopic improvement in contrast with only 4 of 10 patients treated with BDP. Endocrinologic evaluation showed a significant decrease in morning plasma cortisol, in cortisol increase after synacthen, and in urinary free cortisol excretion after PP therapy, but no changes in these variables after BDP therapy. We conclude that PP enemas are more active in the treatment of ulcerative proctitis, but they cause a suppression of the adrenal cortex, in contrast to BDP.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3047215     DOI: 10.1097/00004836-198804000-00013

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  13 in total

1.  Predictive value of inflammatory and coagulation parameters in the course of severe ulcerative colitis.

Authors:  R K Linskens; A A van Bodegraven; M Schoorl; H A Tuynman; P Bartels
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

2.  Elevated plasma von Willebrand factor levels in patients with active ulcerative colitis reflect endothelial perturbation due to systemic inflammation.

Authors:  Petros Zezos; Georgia Papaioannou; Nikolaos Nikolaidis; Themistoclis Vasiliadis; Olga Giouleme; Nikolaos Evgenidis
Journal:  World J Gastroenterol       Date:  2005-12-28       Impact factor: 5.742

Review 3.  A practical guide to the management of distal ulcerative colitis.

Authors:  S Ardizzone; G Bianchi Porro
Journal:  Drugs       Date:  1998-04       Impact factor: 9.546

4.  Formulation and stability of a beclomethasone dipropionate enema.

Authors:  L M Stolk; M Gerrits; E H Wiltink; C J Mulder; G N Tytgat
Journal:  Pharm Weekbl Sci       Date:  1989-02-24

5.  Fluticasone propionate in Crohn's disease.

Authors:  M C de Kaski; A M Peters; J P Lavender; H J Hodgson
Journal:  Gut       Date:  1991-06       Impact factor: 23.059

6.  Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysis.

Authors:  J K Marshall; E J Irvine
Journal:  Gut       Date:  1997-06       Impact factor: 23.059

7.  Ulcerative proctitis.

Authors:  Charles B Whitlow
Journal:  Clin Colon Rectal Surg       Date:  2004-02

8.  Glucocorticosteroids in the treatment of inflammatory bowel disease and approaches to minimizing systemic activity.

Authors:  Cosimo Prantera; Stefano Marconi
Journal:  Therap Adv Gastroenterol       Date:  2013-03       Impact factor: 4.409

9.  The gastrointestinal passage and release of beclomethasone dipropionate from oral delivery systems in ileostomy volunteers.

Authors:  J Burggraaf; A D van Haarst; P Fockens; H C Schoemaker; W J Krauwinkel; A F Cohen
Journal:  Br J Clin Pharmacol       Date:  1998-09       Impact factor: 4.335

Review 10.  Efficacy and Safety of Oral Beclomethasone Dipropionate in Ulcerative Colitis: A Systematic Review and Meta-Analysis.

Authors:  Francesco Manguso; Raffaele Bennato; Giovanni Lombardi; Elisabetta Riccio; Giuseppe Costantino; Walter Fries
Journal:  PLoS One       Date:  2016-11-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.